{"name":"Zoetis Inc.","slug":"zoetis","ticker":"ZTS","exchange":"NYSE","domain":"zoetis.com","description":"Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.","hq":"Parsippany, NJ","founded":2013,"employees":"14500","ceo":"Kristin Peck","sector":"Animal Health","stockPrice":74.6,"stockChange":0.26,"stockChangePercent":0.35,"marketCap":"$31.3B","metrics":{"revenue":9530999808,"revenueGrowth":2.9,"grossMargin":71.8,"rdSpend":0,"netIncome":2673000000,"cash":1940999936,"dividendYield":2.85,"peRatio":12.2,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Apocelin patent cliff ($1.2B at risk)","drug":"Apocelin","type":"patent_expiry","sentiment":"negative"},{"date":"2028-06-01","label":"Convenia patent cliff ($0.5B at risk)","drug":"Convenia","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-01","type":"earnings","headline":"Zoetis Reports Fourth-Quarter and Full-Year 2023 Results","summary":"Zoetis reported fourth-quarter and full-year 2023 results, with revenue increasing 8% and 10%, respectively, compared to the same periods in 2022.","drugName":"","sentiment":"positive"},{"date":"2023-11-01","type":"deal","headline":"Zoetis Acquires European Animal Health Business from Virbac","summary":"Zoetis acquired Virbac's European animal health business, expanding its presence in the region.","drugName":"","sentiment":"positive"},{"date":"2023-06-01","type":"regulatory","headline":"FDA Approves Zoetis' Simparica Trio for Flea, Tick, and Mite Prevention","summary":"The FDA approved Simparica Trio for the prevention of flea, tick, and mite infestations in dogs.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPanZRdk56NGRHTTRhS3ZpLUdFSU1seXB2SUh6QlEzLVEyd2VoS0dyQkl2a1pWcTdZa0dwZHlHcUh3Sk52VmdlWWZXMzBTcXdRNWVyS2tjU1lmX3BwbVMwNVUxX0t3WnJjeEV2eGdGanh5cWxCWjVuR0JvYUFvelY5LTVHS1lfOXFtc1lDTnN3?oc=5","date":"2026-03-18","type":"earnings","source":"Yahoo Finance","summary":"Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Zoetis (NYSE:ZTS) - Yahoo Finance","headline":"Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Zoetis (NYSE:ZTS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE53Ulc0MVRkanRrTk40aHM3OVZvMGVnbjZsNlBIdldiTGhNSW50Q2Vkel9nbVlTWks5SWVvSUMxTVM5YTR5a0FuMDV5WEhQSnRUUG1pTTZYbmJUcWhaSS1yaFZMZG5kZmxBaU5oUkZn?oc=5","date":"2026-03-05","type":"deal","source":"Morningstar","summary":"The Best Healthcare Stocks to Buy - Morningstar","headline":"The Best Healthcare Stocks to Buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPZEs1YkluTTZ6YWRSLUJjdHhBQUVoVmR5bTB2Ylk4Y1dhZXZvY3FZYlZRdUx4TE1NUGZJWktuOGFSRHBCS09Oemd2NkJ4UktqRGtZbjVRQlVPclFpY3RZbDNEeFdkLXFjT19yTGJJai1XWXpuQmNENk1YZ0FIQlhqU0d6YTk?oc=5","date":"2026-02-23","type":"regulatory","source":"Yahoo Finance","summary":"Barclays Remains a Hold on Zoetis Inc. (ZTS) - Yahoo Finance","headline":"Barclays Remains a Hold on Zoetis Inc. (ZTS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOQ1J4c2ZjcGtWcHBpR0xLckljLWF3eFpDRVBQV3RDbUVIbjdCMXBZelQ3U2x3c0FPMmdrX1VueC1TUFNTbXZNbU4xdTBwaFptT3hGaHJoU1ktV1dWMWhmeC15T29UWXZPaEJFRGI0cTlic0tUbFZwYUZjM3Q5WkpNaEJiYTlTbHY3bEU1X2FTMEtELTNESFVXQlRrX0paWEJacU5RWUZ2ejBIVGo4M2FoVUxvTmNZRlhIRF9kTw?oc=5","date":"2026-02-03","type":"earnings","source":"TradingView","summary":"5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates - TradingView","headline":"5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFB6NWdscFh0MzRZWklNNzhIYy1wWnRYOWtCMDlHaEhINXJqeXplc1diRkV4OUQtUVgzNDl1UlBOb1dHWko5bzhFRXJSRm1zOWlJbUlBeFUtcnRLUDhEaFBCa196X2VGNzdWaW9fc191bVFNeHZmaFVDd2UwTDJJZw?oc=5","date":"2026-02-03","type":"pipeline","source":"Yahoo Finance","summary":"Zoetis (ZTS) Traded Lower Due to Reduced 2026 Outlook - Yahoo Finance","headline":"Zoetis (ZTS) Traded Lower Due to Reduced 2026 Outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOT2pkY3IydnF2X2t3VGg1ZWV0T1RacFhOMnBsSkE5djF0REVuNWJ2eFNuNldqYUQtZ2ZlUlJuSUw0MTltUTEyUldBdzdub1dmNTJreVRhXzNuOHI5cU0tZHlreVdvM1gtUUVJRmo0QzdkeXl1b2VKU1pJTEpUWUk4ZTNoNWRYZ0s2TzZJN3RGSG9xRW9fcnU3UG4wQWtUNW4taGNEM2FVQUFyY0o4aXJFb1lzUU42eDZZX3c?oc=5","date":"2026-01-20","type":"earnings","source":"Finviz","summary":"Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment - Finviz","headline":"Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPTGo4RlRTZlBraWdwNFgyN2Q0UkVuWkxKemFIVzJpWlRXYnlfa3Vtb3ZpRGxaSnQtRENZYjZ5NFVQRXNKZmx2V3p2Rk5ZeDh0aDlfMENBLUJGTEtCZWlzazdYa3c4bUdMYnpSN1h1RGZicmZ5VTRlb0FkSnVKZ1Z5QXlLM2hWd1BFVlV2enlGQU9PNHFhemVuVGE3R1pKdw?oc=5","date":"2025-11-06","type":"pipeline","source":"Kalkine Media","summary":"Zoetis (NYSE:ZTS) S&P 500 Chart Mirrors Pharma Momentum - Kalkine Media","headline":"Zoetis (NYSE:ZTS) S&P 500 Chart Mirrors Pharma Momentum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPdEFkLTdTYWsycnBPWm5xNzM5VGNRTTJjVml6YkdZalV6bl9PWDdySEI2SXk5QmVuSVFVMmgtbkFIOFk3VkF0S3hqMmZxb05sS3JqUEloRks0MFo4NEZuaGk0dThpVEdqMlJRN2VIQWhiS0JQQTNCcDJCUWFjenJDYVowZnMxM1R2SGFhNUlXUjVXS0dBcnl3Ty1VWjVlWXNwc2ZpTE5aNGJYUXNLa3JGUE1BY1FIWHUycHB0emlSWS1yaG15QnhGdXJ3VHVMa2_SAdQBQVVfeXFMTlJUYTNUYWdIeHNpSy1UcUVvcWoyemRfYWpZbnF3NWluLTFzUDNYVkp0cks0YVZCdjJYR1gyS0ZBYjdwdGRxeTNLMVY4YjI0ZEUxbEVpVUpPQ19HNmdBbjJDTzFSUmJtODl6bXFWTDJHanZCWmVVQjJnZkEzcmtrTXI2MkVLUzlxMUpxalpzdFE3bDU2WTR5VVBFZHlmQkZqWXI3Q1pIa2xaQ2ZDOHdXSl9YNG1KcXZFQkJfYU55RmhTaV9qUTRFX3FzM0xQY3NJVnpFdHY?oc=5","date":"2025-10-28","type":"pipeline","source":"simplywall.st","summary":"Here's What We Like About Zoetis' (NYSE:ZTS) Upcoming Dividend - simplywall.st","headline":"Here's What We Like About Zoetis' (NYSE:ZTS) Upcoming Dividend","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNckR0R1g5S25VOUppQzhBbWFXX2FOOU9QNi04bW12Sl9nNGtoaVBabGQ5cndtbEhDMEJDTktqV1dRVmNKOW5waTFwUTFFajBpU0NQMjZyVVFhbnlQbFhtd3Fhak54ZUZpMmYtLVpXRXNYbm1oak8tTnBMbllDTmduaE5xQmQ2Z3VxT3gyNWtvWFljcE1Hb3d3cUFBRFZjY01vaktSX3hET2hNQWkxUFE0U21pZmJobnZoTnhr?oc=5","date":"2025-08-05","type":"regulatory","source":"Barron's","summary":"S&P 500 Futures Climb in Premarket Trading; Vertex Pharmaceuticals, Gartner Lag - Barron's","headline":"S&P 500 Futures Climb in Premarket Trading; Vertex Pharmaceuticals, Gartner Lag - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQUU1wa2o5UmE1bGxEUWwtRy1LcnQ0V0RSYklPT2EtUXIxSGJhSmM1blFMNlY3VVB0bDdUWFRhWTlnSUdVREJBM3JoSTIwRjZoclA4Mk5jZ2wzaDhLWHJtUTZpcmJlanZnLXZDRFpZVWV0ZUFfaFBMeU9rY1hGRWZMaXZKSnZqV3p4YUNSejVpMWJpZDZJa0VoUE9DX0VhaGtVdmNwQmF2NVA2NXNEM1ZkLVo3WTFkUWRU?oc=5","date":"2025-07-18","type":"deal","source":"Seeking Alpha","summary":"Zoetis: Poised For Growth Yet Priced For Decline (Rating Upgrade To Strong Buy) (NYSE:ZTS) - Seeking Alpha","headline":"Zoetis: Poised For Growth Yet Priced For Decline (Rating Upgrade To Strong Buy) (NYSE:ZTS)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-30","type":"pipeline","source":"simplywall.st","summary":"Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet? - simplywall.st","headline":"Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE4yVWVmNWJ2cW9wV3ZOSEk4TW1vN0F0NFVMd3JaZl9wQ1hnRFdvWTdMRDcxQ0pRNEpOWVZBU200Y2lFZndERVctRG45QXRqRGp6Slk4?oc=5","date":"2025-05-03","type":"pipeline","source":"StockStory","summary":"Zoetis (ZTS) Research Report - StockStory","headline":"Zoetis (ZTS) Research Report","sentiment":"neutral"}],"patents":[{"drugName":"Apocelin","drugSlug":"apocelin","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":1200000000},{"drugName":"Convenia","drugSlug":"convenia","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":500000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Merck Animal Health","Elanco Animal Health","Boehringer Ingelheim Animal Health"],"therapeuticFocus":["Companion Animals","Livestock","Aquaculture"],"financials":{"source":"sec_edgar+yahoo","revenue":9467000000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":9467000000,"period":"2025-12-31"},{"value":9256000000,"period":"2024-12-31"},{"value":9256000000,"period":"2024-12-31"},{"value":8544000000,"period":"2023-12-31"},{"value":8544000000,"period":"2023-12-31"}],"grossProfit":6801000000,"grossProfitHistory":[{"period":"2025-12-31","value":6801000000},{"period":"2024-12-31","value":6537000000},{"period":"2023-12-31","value":5983000000},{"period":"2022-12-31","value":5626000000}],"rdSpend":698000000,"rdSpendHistory":[{"period":"2025-12-31","value":698000000},{"period":"2024-12-31","value":686000000},{"period":"2023-12-31","value":614000000},{"period":"2022-12-31","value":539000000}],"sgaSpend":2378000000,"operatingIncome":3597000000,"operatingIncomeHistory":[{"period":"2025-12-31","value":3597000000},{"period":"2024-12-31","value":3392000000},{"period":"2023-12-31","value":3069000000},{"period":"2022-12-31","value":2928000000}],"netIncome":2673000000,"netIncomeHistory":[{"period":"2025-12-31","value":2673000000},{"period":"2024-12-31","value":2486000000},{"period":"2023-12-31","value":2344000000},{"period":"2022-12-31","value":2114000000}],"eps":6.02,"epsHistory":[{"period":"2025-12-31","value":6.02},{"period":"2024-12-31","value":5.47},{"period":"2023-12-31","value":5.07},{"period":"2022-12-31","value":4.49}],"cash":2310000000,"cashHistory":[{"period":"2025-12-31","value":2310000000},{"period":"2024-12-31","value":1985000000},{"period":"2023-12-31","value":2039000000},{"period":"2022-12-31","value":3577000000}],"totalAssets":15467000000,"totalLiabilities":12136000000,"totalDebt":9238000000,"equity":3331000000,"operatingCashflow":2904000000,"operatingCashflowHistory":[{"period":"2025-12-31","value":2904000000},{"period":"2024-12-31","value":2953000000},{"period":"2023-12-31","value":2353000000},{"period":"2022-12-31","value":1912000000}],"capex":-621000000,"capexHistory":[{"period":"2025-12-31","value":-621000000},{"period":"2024-12-31","value":-655000000},{"period":"2023-12-31","value":-732000000},{"period":"2022-12-31","value":-586000000}],"freeCashflow":2283000000,"dividendsPaid":-889000000,"buybacks":-3235000000,"employees":14500,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":588000000,"ebit":820000000,"ebitda":939000000,"period":"2026-03-31","revenue":2262000000,"epsBasic":1.42,"netIncome":601000000,"rdExpense":180000000,"epsDiluted":1.42,"grossProfit":1621000000,"operatingIncome":822000000},{"sga":619000000,"ebit":818000000,"ebitda":939000000,"period":"2025-12-31","revenue":2387000000,"epsBasic":1.38,"netIncome":603000000,"rdExpense":199000000,"epsDiluted":1.37,"grossProfit":1675000000,"operatingIncome":826000000},{"sga":579000000,"ebit":945000000,"ebitda":1069000000,"period":"2025-09-30","revenue":2400000000,"epsBasic":1.63,"netIncome":721000000,"rdExpense":170000000,"epsDiluted":1.63,"grossProfit":1717000000,"operatingIncome":936000000},{"sga":617000000,"ebit":955000000,"ebitda":1078000000,"period":"2025-06-30","revenue":2460000000,"epsBasic":1.61,"netIncome":718000000,"rdExpense":172000000,"epsDiluted":1.61,"grossProfit":1811000000,"operatingIncome":989000000},{"sga":574000000,"ebit":827000000,"ebitda":946000000,"period":"2025-03-31","revenue":2198000000,"epsBasic":1.34,"netIncome":602000000,"rdExpense":162000000,"epsDiluted":1.34,"grossProfit":1580000000,"operatingIncome":812000000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":74.6,"previousClose":74.34,"fiftyTwoWeekHigh":172.23,"fiftyTwoWeekLow":74.29,"fiftyTwoWeekRange":"74.29 - 172.23","fiftyDayAverage":113.98,"twoHundredDayAverage":129.84,"beta":0.86,"enterpriseValue":38478417920,"forwardPE":10,"priceToBook":9.52,"priceToSales":3.28,"enterpriseToRevenue":4.04,"enterpriseToEbitda":9.45,"pegRatio":1.54,"ebitda":4073999872,"ebitdaMargin":42.7,"freeCashflow":1780875008,"operatingCashflow":2790000128,"totalDebt":9253999616,"debtToEquity":286.2,"currentRatio":3.15,"returnOnAssets":15.5,"returnOnEquity":67.7,"analystRating":"2.0 - Buy","recommendationKey":"buy","numberOfAnalysts":17,"targetMeanPrice":130.82,"targetHighPrice":160,"targetLowPrice":90,"dividendRate":2.12,"payoutRatio":0.33,"fiveYearAvgDividendYield":0.92,"exDividendDate":1776643200,"insiderHeldPercent":0.1,"institutionHeldPercent":102.3,"sharesOutstanding":419228118,"floatShares":418398046,"sharesShort":14800585,"shortRatio":4.54,"shortPercentOfFloat":3.5,"epsTrailing":6.1,"epsForward":7.47,"revenuePerShare":21.81,"bookValue":7.84,"officers":[{"age":54,"name":"Ms. Kristin C. Peck","title":"CEO & Director"},{"age":53,"name":"Mr. Wetteny N. Joseph CPA","title":"Executive VP & CFO"},{"age":60,"name":"Ms. Roxanne  Lagano","title":"Executive VP, General Counsel & Corporate Secretary"},{"age":55,"name":"Dr. Robert J. Polzer Ph.D.","title":"Scientific Advisor"},{"age":51,"name":"Mr. Jamie  Brannan","title":"Executive VP & Chief Commercial Officer"},{"age":46,"name":"Mr. Keith  Sarbaugh","title":"Executive VP & Chief Digital and Technology Officer"},{"age":null,"name":"Mr. Steven  Frank","title":"Vice President of Investor Relations"},{"age":52,"name":"Ms. Julie A. Fuller","title":"Executive VP, Chief Human Resources Officer & Global Operations"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.zoetis.com","phone":"973 822 7000"}}